Physicians should avoid prescribing it to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Individuals with severe gastrointestinal conditions, such as gastroparesis. Patients with a known allergy to GLP-1 receptor agonists. Pregnant or breastfeeding women, unless approved by a physician
Does this change the unit-to-mg conversion for semaglutide
Common side effects mirror those of the GLP-1 class primarily nausea, vomiting, and diarrhoea and are most pronounced during dose escalation
Cold foods that are low in fat and mild in flavor tend to be best tolerated
This product is not classified as a drug, food, or cosmetic
[DOI] [PubMed] [Google Scholar] 46.Huang C., Zhang Y., Gong Z